Peer-influenced content. Sources you trust. No registration required. This is HCN.
OBR Oncology
In a recent comprehensive review, 15.2% of oncology conference abstracts used language that minimized treatment toxicities, potentially leading to misinformed treatment plans and impacting patient care. A call to action for clearer, data-driven communication in the field.
Hematology/Oncology January 8th 2024
DocWire News
Discover how STRIDE is setting new benchmarks in the treatment of unresectable hepatocellular carcinoma, offering both improved survival rates and a tolerable safety profile.
Hepatology October 9th 2023
Clinical Advisor
New reports and studies are raising concerns about the gastrointestinal safety of semaglutide-containing medications; clinicians are advised to exercise caution and monitor patients for symptoms of gastroparesis.
Endocrinology, Diabetes, Metabolism October 4th 2023
Ophthalmology Advisor
Understanding the ocular side effects of targeted cancer therapies is crucial. Early monitoring and interdisciplinary communication can significantly impact treatment outcomes.
Ophthalmology September 26th 2023
Annals of Internal Medicine
This retrospective cohort study provides evidence that the risk profiles for in-hospital adverse events are similar among haloperidol and atypical antipsychotics in older patients with postoperative delirium.
Hospitalist September 12th 2023
Hematology Advisor
New research indicates that maternal hemoglobin levels can significantly impact both maternal and neonatal health outcomes, suggesting a need for revised antenatal care guidelines.
Hematology September 11th 2023